GANX
Price
$1.69
Change
+$0.06 (+3.68%)
Updated
Jul 3 closing price
Capitalization
50.61M
31 days until earnings call
IPA
Price
$1.31
Change
+$0.25 (+23.58%)
Updated
Jul 3 closing price
Capitalization
59.95M
Interact to see
Advertisement

GANX vs IPA

Header iconGANX vs IPA Comparison
Open Charts GANX vs IPABanner chart's image
Gain Therapeutics
Price$1.69
Change+$0.06 (+3.68%)
Volume$244.35K
Capitalization50.61M
ImmunoPrecise Antibodies
Price$1.31
Change+$0.25 (+23.58%)
Volume$2.71M
Capitalization59.95M
GANX vs IPA Comparison Chart in %
Loading...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GANX vs. IPA commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a Hold and IPA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (GANX: $1.69 vs. IPA: $1.31)
Brand notoriety: GANX and IPA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 82% vs. IPA: 114%
Market capitalization -- GANX: $50.61M vs. IPA: $59.95M
GANX [@Biotechnology] is valued at $50.61M. IPA’s [@Biotechnology] market capitalization is $59.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileIPA’s FA Score has 0 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • IPA’s FA Score: 0 green, 5 red.
According to our system of comparison, IPA is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 3 TA indicator(s) are bullish while IPA’s TA Score has 3 bullish TA indicator(s).

  • GANX’s TA Score: 3 bullish, 6 bearish.
  • IPA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IPA is a better buy in the short-term than GANX.

Price Growth

GANX (@Biotechnology) experienced а -15.08% price change this week, while IPA (@Biotechnology) price change was +18.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.52%. For the same industry, the average monthly price growth was +13.89%, and the average quarterly price growth was -0.53%.

Reported Earning Dates

GANX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+5.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPA($60M) has a higher market cap than GANX($50.6M). IPA YTD gains are higher at: 218.193 vs. GANX (-21.759). GANX has higher annual earnings (EBITDA): -20.26M vs. IPA (-45.11M). IPA has more cash in the bank: 12.9M vs. GANX (9.07M). GANX has less debt than IPA: GANX (607K) vs IPA (12.9M). IPA has higher revenues than GANX: IPA (24M) vs GANX (0).
GANXIPAGANX / IPA
Capitalization50.6M60M84%
EBITDA-20.26M-45.11M45%
Gain YTD-21.759218.193-10%
P/E RatioN/AN/A-
Revenue024M-
Total Cash9.07M12.9M70%
Total Debt607K12.9M5%
FUNDAMENTALS RATINGS
IPA: Fundamental Ratings
IPA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GANXIPA
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
86%
Bearish Trend 5 days ago
86%
Momentum
ODDS (%)
Bearish Trend 5 days ago
89%
N/A
MACD
ODDS (%)
Bearish Trend 5 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 20 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 27 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
87%
Bullish Trend 5 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PBSFY2.06N/A
N/A
ProSiebenSat.1 Media SE
TPCFF0.52N/A
N/A
Titan Logix Corp.
RPNMF2.86N/A
N/A
Rapala Network Corp.
LCNTU511.00N/A
N/A
Louisiana Central Oil & Gas Co.
KPCPY18.93-0.65
-3.30%
KASIKORNBANK Public Co. Ltd.

GANX and

Correlation & Price change

A.I.dvisor tells us that GANX and COYA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GANX and COYA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+3.36%
COYA - GANX
32%
Poorly correlated
+3.11%
OCUL - GANX
32%
Poorly correlated
+1.69%
MGTX - GANX
31%
Poorly correlated
+8.53%
TPST - GANX
31%
Poorly correlated
N/A
RXRX - GANX
30%
Poorly correlated
+1.15%
More

IPA and

Correlation & Price change

A.I.dvisor tells us that IPA and TPST have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPA and TPST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPA
1D Price
Change %
IPA100%
+23.58%
TPST - IPA
28%
Poorly correlated
N/A
ITRM - IPA
23%
Poorly correlated
-0.42%
LTRN - IPA
23%
Poorly correlated
+2.20%
GANX - IPA
23%
Poorly correlated
+3.36%
ABCL - IPA
22%
Poorly correlated
+1.33%
More